Clinical Trial Update: Adverse Event Data Collection From the EUHASS Registry on Turoctocog Alfa Pegol

View source ↗

Summary

An ongoing clinical trial update reports adverse event data collection from the EUHASS registry for turoctocog alfa pegol in patients with Hemophilia A.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Esperoct (turoctocog alfa pegol)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Haemophilia A | Status: ENROLLING_BY_INVITATION